ATE525100T1 - Poröse matrix - Google Patents

Poröse matrix

Info

Publication number
ATE525100T1
ATE525100T1 AT04724075T AT04724075T ATE525100T1 AT E525100 T1 ATE525100 T1 AT E525100T1 AT 04724075 T AT04724075 T AT 04724075T AT 04724075 T AT04724075 T AT 04724075T AT E525100 T1 ATE525100 T1 AT E525100T1
Authority
AT
Austria
Prior art keywords
matrix
porous matrix
tissue
target tissue
seeded
Prior art date
Application number
AT04724075T
Other languages
English (en)
Inventor
Richard France
Robin Quirk
Original Assignee
Regentec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regentec Ltd filed Critical Regentec Ltd
Application granted granted Critical
Publication of ATE525100T1 publication Critical patent/ATE525100T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04724075T 2003-03-27 2004-03-29 Poröse matrix ATE525100T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307011.7A GB0307011D0 (en) 2003-03-27 2003-03-27 Porous matrix
PCT/GB2004/001419 WO2004084968A1 (en) 2003-03-27 2004-03-29 Porous matrix

Publications (1)

Publication Number Publication Date
ATE525100T1 true ATE525100T1 (de) 2011-10-15

Family

ID=9955594

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04724075T ATE525100T1 (de) 2003-03-27 2004-03-29 Poröse matrix

Country Status (10)

Country Link
US (2) US10232087B2 (de)
EP (1) EP1605984B1 (de)
JP (1) JP4818905B2 (de)
CN (1) CN100566763C (de)
AT (1) ATE525100T1 (de)
AU (1) AU2004224547B2 (de)
CA (1) CA2520398C (de)
ES (1) ES2373955T3 (de)
GB (2) GB0307011D0 (de)
WO (1) WO2004084968A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0116341D0 (en) 2001-07-04 2001-08-29 Smith & Nephew Biodegradable polymer systems
GB0202233D0 (en) 2002-01-31 2002-03-20 Smith & Nephew Bioresorbable polymers
GB0307011D0 (en) * 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
GB0329654D0 (en) 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US8012210B2 (en) 2004-01-16 2011-09-06 Warsaw Orthopedic, Inc. Implant frames for use with settable materials and related methods of use
AU2007207429A1 (en) 2006-01-19 2007-07-26 Warsaw Orthopedic, Inc. Injectable and moldable bone substitute materials
CA2637606C (en) 2006-01-19 2013-03-19 Osteotech, Inc. Porous osteoimplant
WO2008058323A1 (en) 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
AU2007325001B2 (en) 2006-11-30 2014-04-10 Smith & Nephew, Inc. Fiber reinforced composite material
WO2008067655A1 (en) * 2006-12-05 2008-06-12 Q6 Biomaterials Inc. Biocompatible hydrogel-based scaffolds
GB0701896D0 (en) * 2007-02-01 2007-03-14 Regentec Ltd Composition
US9815240B2 (en) 2007-04-18 2017-11-14 Smith & Nephew, Inc. Expansion moulding of shape memory polymers
ATE547129T1 (de) 2007-04-19 2012-03-15 Smith & Nephew Inc Multimodale formgedächtnis-polymere
US9770534B2 (en) 2007-04-19 2017-09-26 Smith & Nephew, Inc. Graft fixation
US20100331254A1 (en) * 2007-12-26 2010-12-30 Metamorefix Pulverized fibrin clots and pharmaceutical compositions containing them
CA2752419A1 (en) 2009-01-12 2010-07-15 Hadasit Medical Research Services & Development Limited Tissue regeneration membrane
GB0903810D0 (en) 2009-03-05 2009-04-22 Regentec Ltd Delivery system
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US11045500B2 (en) 2011-02-14 2021-06-29 Technion Research Development Foundation Ltd. Tissue engineering construct comprising fibrin
CN102266590B (zh) * 2011-07-15 2013-10-09 陕西师范大学 壳聚糖/羟基磷灰石三维多孔支架材料的制备方法
US10369248B2 (en) * 2014-07-29 2019-08-06 The United States Of America As Represented By The Secretary Of The Army Porous polymer composites
JP6847848B2 (ja) 2014-12-15 2021-03-24 ザ ジョーンズ ホプキンズ ユニバーシティＴｈｅ Ｊｏｈｎｓ Ｈｏｐｋｉｎｓ Ｕｎｉｖｅｒｓｉｔｙ スニチニブ製剤、及び緑内障の治療におけるその使用方法
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
HK1257499A1 (zh) 2015-11-12 2019-10-25 Graybug Vision, Inc. 用於治疗的聚集性微粒
CA3018629A1 (en) 2016-03-24 2017-09-28 Locate Therapeutics Limited Scaffolding material, methods and uses
GB201702475D0 (en) * 2017-02-15 2017-03-29 Locate Therapeutics Ltd Tissue scaffold and scaffold composition
EP3600324A4 (de) 2017-03-23 2020-12-09 Graybug Vision, Inc. Arzneimittel und zusammensetzungen zur behandlung von augenkrankheiten
WO2018191274A1 (en) * 2017-04-11 2018-10-18 University Of Florida Research Foundation Systems and methods for in-situ, bottom-up tissue generation
AU2018265415A1 (en) 2017-05-10 2019-10-31 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
GB201710414D0 (en) 2017-06-29 2017-08-16 Univ Nottingham Chemotherapy
CN109141693B (zh) * 2018-06-25 2021-01-15 厦门大学 一种柔性压力传感器及其制备方法
CN110585486B (zh) * 2019-08-28 2021-11-30 湖南光琇医院有限公司 羊膜复合材料及其制备方法和应用
GB202106973D0 (en) 2021-05-14 2021-06-30 Locate Bio Ltd Osteoconductive implant material with BMP-2 delivery

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB215832A (en) 1923-02-14 1924-05-14 James Ernest Johnson Improvements in and relating to means for deaerating water and particularly feed water for steam boilers
US4997443A (en) * 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5725491A (en) * 1988-10-03 1998-03-10 Atrix Laboratories, Inc. Method of forming a biodegradable film dressing on tissue
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5632727A (en) * 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
GB2227176B (en) 1988-12-12 1993-01-20 Bioplasty Inc Textured micro implants
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5077049A (en) * 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
US5344701A (en) * 1992-06-09 1994-09-06 Minnesota Mining And Manufacturing Company Porous supports having azlactone-functional surfaces
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
EP2025353A2 (de) * 1993-04-30 2009-02-18 Massachusetts Institute of Technology Injizierbare Polysaccharid-Zell-Zusammensetzungen
US5502092A (en) * 1994-02-18 1996-03-26 Minnesota Mining And Manufacturing Company Biocompatible porous matrix of bioabsorbable material
AU1287895A (en) 1994-10-03 1996-04-26 Otogen Corporation Differentially biodegradable biomedical implants
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US5676976A (en) * 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US6287341B1 (en) * 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6132463A (en) * 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US6117456A (en) * 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US6541037B1 (en) * 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US20020136696A1 (en) * 1995-05-19 2002-09-26 Dosuk D. Lee Orthopedic and dental ceramic implants
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US5677284A (en) * 1995-06-06 1997-10-14 Regen Biologics, Inc. Charged collagen particle-based delivery matrix
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5776193A (en) * 1995-10-16 1998-07-07 Orquest, Inc. Bone grafting matrix
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US6953594B2 (en) * 1996-10-10 2005-10-11 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
ES2299183T3 (es) * 1996-10-16 2008-05-16 Etex Corporation Composiciones bioceramicas.
DE69729647T2 (de) 1996-10-16 2005-07-07 Etex Corp., Cambridge Verfahren zur Herstellung von wenigkristallinem Calciumphosphat und Verfahren zu dessen Verwendung
US5866155A (en) * 1996-11-20 1999-02-02 Allegheny Health, Education And Research Foundation Methods for using microsphere polymers in bone replacement matrices and composition produced thereby
GB9704749D0 (en) * 1997-03-07 1997-04-23 Univ London Tissue Implant
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
AU8681098A (en) * 1997-08-01 1999-03-08 Massachusetts Institute Of Technology Three-dimensional polymer matrices
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
US20020164374A1 (en) * 1997-10-29 2002-11-07 John Jackson Polymeric systems for drug delivery and uses thereof
CA2221195A1 (en) * 1997-11-14 1999-05-14 Chantal E. Holy Biodegradable polymer matrix
US6143293A (en) 1998-03-26 2000-11-07 Carnegie Mellon Assembled scaffolds for three dimensional cell culturing and tissue generation
US6841617B2 (en) * 2000-09-28 2005-01-11 Battelle Memorial Institute Thermogelling biodegradable aqueous polymer solution
WO2000007639A1 (en) * 1998-08-07 2000-02-17 Tissue Engineering, Inc. Bone precursor compositions
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US7022522B2 (en) * 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
GB9826701D0 (en) 1998-12-05 1999-01-27 Univ Newcastle Microcellular polymers as cell growth media and novel polymers
US6376742B1 (en) * 1999-02-17 2002-04-23 Richard J. Zdrahala In vivo tissue engineering with biodegradable polymers
AU4977800A (en) 1999-04-26 2000-11-10 California Institute Of Technology (in situ) forming hydrogels
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
JP4433430B2 (ja) * 1999-08-06 2010-03-17 株式会社クラレ 医療用高分子ゲルおよびその製造方法
DE19956503A1 (de) 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
GB9927850D0 (en) 1999-11-26 2000-01-26 Univ Nottingham Microporous polymer matrices
WO2001049240A2 (en) * 2000-01-05 2001-07-12 Novartis Ag Hydrogels
GB2363115A (en) * 2000-06-10 2001-12-12 Secr Defence Porous or polycrystalline silicon orthopaedic implants
US20020076443A1 (en) 2000-06-19 2002-06-20 Stanley Stein Multiple phase cross-linked compositions and uses thereof
GB0015430D0 (en) 2000-06-24 2000-08-16 Victrex Mfg Ltd Bio-compatible polymeric materials
US6638312B2 (en) 2000-08-04 2003-10-28 Depuy Orthopaedics, Inc. Reinforced small intestinal submucosa (SIS)
US8366787B2 (en) * 2000-08-04 2013-02-05 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
CN1156253C (zh) 2000-08-17 2004-07-07 中国科学院化学研究所 周围神经修复用组织工程诱导支架
US6521258B1 (en) 2000-09-08 2003-02-18 Ferro Corporation Polymer matrices prepared by supercritical fluid processing techniques
GB2370777B (en) 2001-01-06 2002-12-31 Roozbeh Shirandami Biodegradable tissue scafold and bone template
US6675118B2 (en) 2001-03-19 2004-01-06 Hewlett-Packard Development Company, L.P. System and method of determining the noise sensitivity characterization for an unknown circuit
JP2002325831A (ja) * 2001-05-02 2002-11-12 Asahi Optical Co Ltd 生体用充填材、および生体用充填材の製造方法
US6444222B1 (en) * 2001-05-08 2002-09-03 Verigen Transplantation Services International Ag Reinforced matrices
US20020183858A1 (en) * 2001-06-05 2002-12-05 Contiliano Joseph H. Attachment of absorbable tissue scaffolds to scaffold fixation devices
WO2003007786A2 (en) 2001-07-16 2003-01-30 Depuy Products, Inc. Porous delivery scaffold and method
JP2004535245A (ja) 2001-07-16 2004-11-25 デピュイ・プロダクツ・インコーポレイテッド 多孔質細胞外基質支持骨格材料および方法
JP2005515802A (ja) * 2001-07-16 2005-06-02 デピュイ・プロダクツ・インコーポレイテッド 混成生物／合成品型多孔質細胞外基質支持骨格
US7819918B2 (en) 2001-07-16 2010-10-26 Depuy Products, Inc. Implantable tissue repair device
WO2003007847A1 (en) 2001-07-16 2003-01-30 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorable scaffolds
EP1416886A4 (de) * 2001-07-16 2007-04-18 Depuy Products Inc Gerüst und verfahren für die knorpelreparatur und regeneration
US8025896B2 (en) * 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
AU2002354911B2 (en) * 2001-07-16 2007-08-30 Depuy Products, Inc. Meniscus regeneration device and method
US7163563B2 (en) * 2001-07-16 2007-01-16 Depuy Products, Inc. Unitary surgical device and method
WO2003007839A2 (en) 2001-07-16 2003-01-30 Depuy Products, Inc. Devices form naturally occurring biologically derived
WO2003007805A2 (en) 2001-07-16 2003-01-30 Depuy Products, Inc. Cartilage repair apparatus and method
JP2003024272A (ja) 2001-07-18 2003-01-28 Olympus Optical Co Ltd 信号処理装置
WO2003011343A1 (en) * 2001-07-27 2003-02-13 National Institute Of Advanced Industrial Science And Technology Method of regenerating bone/chondral tissues by transferring transcriptional factor gene
GB0121985D0 (en) 2001-09-11 2001-10-31 Isis Innovation Tissue engineering scaffolds
AU2002327007B2 (en) 2001-09-21 2005-10-20 Stryker Corporation Pore-forming agents for orthopedic cements
US20030059460A1 (en) * 2001-09-27 2003-03-27 Yasuhiko Tabata Hybrid material for regeneration of living body tissue
OA12731A (en) 2001-11-30 2006-06-28 Pfizer Controlled release polymeric compositions of bone growth promoting compounds.
GB0129008D0 (en) 2001-12-04 2002-01-23 Univ London Method for forming matrices of hardened material
WO2003053216A2 (en) 2001-12-06 2003-07-03 University Of Washington Biodegradable, porous structures useful for growing living tissue, and methods of manufacture
US7166133B2 (en) * 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
GB0215832D0 (en) 2002-07-09 2002-08-14 Akay Galip Preparation of composite high internal phase emulsion polymerised microporous polymers and their applications
US20040166169A1 (en) * 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method
AU2002950340A0 (en) 2002-07-23 2002-09-12 Commonwealth Scientific And Industrial Research Organisation Biodegradable polyurethane/urea compositions
EP1433489A1 (de) * 2002-12-23 2004-06-30 Degradable Solutions AG Biologisch abbaubares, poröses Knochenimplantat mit integrierter Abdeckmembrane
US8676853B2 (en) * 2003-02-27 2014-03-18 Hewlett-Packard Development Company, L.P. System and method for software reuse
GB0307011D0 (en) * 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
US20040234571A1 (en) * 2003-05-22 2004-11-25 Jang Bor Z. Direct injection of nano fibers and nano fiber composites for biomedical applications
WO2005086706A2 (en) 2004-03-05 2005-09-22 The Trustees Of Columbia University In The City Of New York Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue to bone
GB0502493D0 (en) 2005-02-07 2005-03-16 Orthogem Ltd Bone cement

Also Published As

Publication number Publication date
GB2415142B (en) 2008-03-05
US20060263335A1 (en) 2006-11-23
GB0307011D0 (en) 2003-04-30
EP1605984A1 (de) 2005-12-21
ES2373955T3 (es) 2012-02-10
CN100566763C (zh) 2009-12-09
US10232087B2 (en) 2019-03-19
US20080241248A1 (en) 2008-10-02
WO2004084968A1 (en) 2004-10-07
CN1816360A (zh) 2006-08-09
HK1086205A1 (zh) 2006-09-15
JP2006521144A (ja) 2006-09-21
EP1605984B1 (de) 2011-09-21
CA2520398C (en) 2013-03-05
US9486558B2 (en) 2016-11-08
GB0518898D0 (en) 2005-10-26
AU2004224547A1 (en) 2004-10-07
AU2004224547B2 (en) 2009-12-10
CA2520398A1 (en) 2004-10-07
GB2415142A (en) 2005-12-21
JP4818905B2 (ja) 2011-11-16

Similar Documents

Publication Publication Date Title
ATE525100T1 (de) Poröse matrix
JP2007517543A5 (de)
EP1425390A4 (de) Material und verfahren zur förderung der reparatur von nervengewebe
EP2420567A3 (de) Verfahren und Zusammensetzungen zur Behandlung von Knochendefekten mit Plazentazellenpopulationen
ATE335439T1 (de) Vorrichtungen zur minimal invasiven einführen von implantaten
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
DK1487461T3 (da) Fremgangsmåder til anvendelse af og præparater omfattende immunomodulatoriske forbindelser til behandling og håndtering af myelodysplastiske syndromer
EA201000953A1 (ru) Медицинский электрод, пучок электродов и массив из пучков электродов
MXPA03001914A (es) Matrices basadas en fibrina electroprocesada y tejidos.
WO2012020412A3 (en) Fibrin based scaffold, preparation and use thereof
SG146691A1 (en) Methods of preparing and using stem cell compositions and kits comprising the same
NO20073959L (no) Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
AU3850600A (en) Dalda analogs and their use
SE0402762D0 (sv) Indazole sulphonamide derivatives
EP1458870A4 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON siRNA, AMPHIPATISCHE VERBINDUNGEN UND POLYKATIONEN
DK1689461T5 (da) Anvendelse af en hydrogel til dyrkning af chondrocytter
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
DK1495051T3 (da) Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler
WO2006073890A3 (en) Use of glp-1 and agonists thereof to prevent cardiac myocyte apoptosis
WO2006000577A3 (en) Lxr agonists to promote bone homeostasis
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
MX2009004295A (es) Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa.
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2005009350A3 (en) Fugetactic proteins, compositions and methods of use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties